Disease Updates

Leishmaniasis is endemic in 80 countries, with an estimated 50,000 to 90,000 new cases reported annually, although WHO estimates that only 25% to 45% of infections are officially documented.

Africa CDC developed the resource through its Hepatitis B Group of Experts, in collaboration with the Centre for Operational Research on Hepatitis B, HEPSANET and the Society for the Study of Liver Disease in Africa.

The campaigns vaccinated 936,618 children during the first round, 997,941 during the second and 1,025,806 during the third.

The country has also discharged its last Ebola patient and entered the 42-day countdown required to declare the outbreak over.

Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.

The EBO-PEP platform trial, which has been under development since 2024, will evaluate several medicines as post-exposure prophylaxis for people who have had high-risk contact with filoviruses, the virus family that includes Bundibugyo Ebola.

Breast cancer remains the country’s most commonly diagnosed cancer, accounting for 5,822 new cases, or 16.2% of all cancers.

The initiative focused on border communities, refugee camps, and other vulnerable areas where frequent cross-border movement increases the risk of disease transmission.

Unlike previous Ebola epidemics caused by the Zaire strain, the current Bundibugyo outbreak has no licensed vaccine or approved treatment, making research an urgent public health priority.